• High-Throughput Measurement of Fractional Killing

  2026-08-18

  Inde, Rodencal, and Dixon present a high-throughput microscopy protocol for measuring drug-induced fractional killing over time rather than relying on a single bulk viability endpoint. The workflow combines nuclear fluorescent labeling of live cells with dead-cell imaging, enabling parallel comparison of hundreds of treatment conditions and analysis of variable responses to MEK1/2 inhibitors.

• EZ Cap™ Cas9 mRNA (m1Ψ) for Precise Editing

  2026-08-17

  Build transient CRISPR workflows around Cap1-capped, m1Ψ-modified Cas9 mRNA for efficient genome editing in mammalian cells. This practical guide connects RNA handling, dose optimization, nuclear-export biology, and troubleshooting to improve reproducibility without overstating product-specific performance.

• MOG (35-55) for Reproducible EAE Research

  2026-08-17

  Build more consistent experimental autoimmune encephalomyelitis models with a defined myelin oligodendrocyte glycoprotein peptide and a workflow that connects disease scoring to mechanistic neuroinflammation assays. This guide translates the latest PARP7–STAT1/STAT2 findings into practical choices for multiple sclerosis research, dose selection, sample handling, and troubleshooting.

• TH287: Turning Oxidative Stress Into Radiosensitivity

  2026-08-16

  A translational analysis of TH287 as an MTH1 inhibitor for cancer research, focusing on oxidized nucleotide sanitization, radiation scheduling, DNA damage biology, and the evidence needed to move from cell-based radiosensitization to a credible therapeutic hypothesis.

• PARP7–STAT1/2 Control of EAE

  2026-08-15

  A 2025 Cell Reports study identifies PARP7 as a suppressor of type I interferon signaling rather than interferon production. By linking STAT1/STAT2 mono-ADP-ribosylation to ubiquitination and p62-dependent autophagic degradation, the work provides a mechanistic explanation for why PARP7 inhibition alleviates experimental autoimmune encephalomyelitis in mice.

• Protoporphyrin IX at the Heme-Ferroptosis Interface

  2026-08-14

  Protoporphyrin IX is more than a heme precursor: it is a photodynamic compound and a powerful experimental lens for studying iron-dependent biology. This article connects its chemistry to ferroptosis assay design while clarifying what recent hepatocellular carcinoma evidence does—and does not—demonstrate.

• Autophagy–Liver Metastasis Signature in CRC

  2026-08-14

  Bai et al. integrated bulk and single-cell transcriptomic evidence to develop a six-gene prognostic signature linking autophagy, liver metastasis, and immune suppression in colorectal cancer. The model improved risk stratification and associated high-risk disease with TIDE-predicted immunotherapy resistance, macrophage polarization, and CD8+ T-cell exhaustion.

• Mouse Tissue Lysis Kit (K1038) Workflow Guide

  2026-08-13

  The Mouse Tissue Lysis Kit (K1038) prepares lysates from mouse tail, toe, or ear tissue for direct PCR-based genotyping without a separate DNA extraction or purification step. It is intended for scientific research, including molecular biology workflows, and must not be used for diagnostic or medical applications.

• Patient-Derived Gastric Cancer Assembloids

  2026-08-13

  The reference study develops gastric cancer assembloids by combining patient-matched tumor organoids with separately expanded stromal subpopulations. Its results show that stromal composition reshapes gene expression and drug sensitivity, making the model useful for studying tumor–stroma interactions, resistance, and personalized treatment responses.

• CAMLs as Blood Biomarkers of Cancer Progression

  2026-08-12

  The reference study positions circulating cancer-associated macrophage-like cells (CAMLs), a blood-borne form of phagocytic polyploid giant cancer cells, as clinically informative markers of progression across multiple solid tumors. Its prospective, multi-institutional design combines clinical correlation with cellular phenotyping, while also clarifying that CAMLs may reflect metastatic-niche biology rather than simply passive tumor debris.

• Measuring Drug Response Beyond Cell Viability

  2026-08-12

  Hannah R. Schwartz’s 2022 dissertation distinguishes relative viability from fractional viability, showing that growth inhibition and cell killing are related but non-equivalent features of anticancer drug response. The framework supports better assay design by pairing proliferation and death measurements and by incorporating their different temporal behaviors into interpretation.

• DPPH Workflow for In Vitro Antioxidant Screening

  2026-08-11

  DPPH provides a fast, plate-compatible readout of electron- and hydrogen-donating activity in purified compounds and complex extracts. This workflow shows how to convert the violet-to-yellow reaction into reliable comparative data, then connect it with metabolomics and orthogonal enzyme assays.

• Meropenem: A Resistance-Aware Research Framework

  2026-08-11

  Meropenem is a β-lactam antibiotic carbapenem with broad experimental utility against Gram-negative and Gram-positive bacteria. This article presents a resistance-aware framework that connects phenotype, carbapenemase gene mobility, plasmid biology, and reproducible assay design.

• ATP Workflows for Mitochondrial Metabolism Research

  2026-08-10

  Use Adenosine Triphosphate as a controlled biochemical input, an energetic readout, and an extracellular signaling probe. This workflow connects ATP handling with native OGDH–TCAIM studies while separating direct enzyme effects from broader mitochondrial and purinergic responses.

• Staurosporine: Mechanism and Research Uses

  2026-08-09

  Staurosporine is a broad-spectrum serine/threonine protein kinase inhibitor used to dissect kinase signaling and induce apoptosis in cancer research. Its activity against PKC isoforms, selected receptor tyrosine kinases, and VEGF-driven angiogenesis supports mechanistic studies, but its broad target profile limits pathway selectivity.

774 records 8/52 page Previous Next First page 上5页 678910 下5页 Last page